CompletedNot Applicable

Risk Factors for Clinically Relevant Postoperative Pancreatic Fistula

Egypt107 participantsStarted 2017-08-01

Plain-language summary

For periampullary and pancreatic head disorders, pancreaticoduodenectomy (PD) is the standard treatment. However, PD is technically demanding and has high morbidity and mortality rates. The most significant and life-threatening complication of PD is postoperative pancreatic fistula (POPF), with reported rates of 5 to 70% for total POPF and 10 to 45% for clinically relevant (CR-POPF). Operative risk variables for CR-POPF after PD were investigated in this study.

Who can participate

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with resectable distal CBD carcinoma, periampullary carcinoma, duodenal carcinoma, and carcinoma of the head of the pancreas.
✓. American Society of Anesthesiologists (ASA) scores I \& II.
✓. Patients aged \> 20 years.
✓. Agreement to complete the study.

Exclusion criteria

✕. Patients with benign disease, trauma, and receive neoadjuvant therapy.
✕. double primary cancers.

What they're measuring

clinically relevant post operative pancreatic fistula

Timeframe: 10 days

Trial details

NCT IDNCT05687825

SponsorSouth Valley University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-07-30

View on ClinicalTrials.gov More Pancreatic Fistula trials